Please login to your online account to display your discounted pricing

Promega™ Recombinant RNasin™ Ribonuclease Inhibitor

Ideal for any application where eukaryotic RNase contamination is a potential problem

$142.58 - $347.92

Specifications

For Use With (Application) RT-PCR, protection of mRNA in cDNA synthesis reactions, in-vitro transcription/translation, Increase yield and activity of polysomes, improvement of in-vitro virus replication, improvement of RNA translation in homologous systems
Storage Requirements Store at -20°C.
View More Specs

 Disclaimers

U.S. Patents 4,966,964, 5,019,556, and 5,266,687; Australian Patents 616881 and 641261, are exclusively licensed to Promega Corporation.
U.S. Patent 5,552,302, Australian Patent 646803.

Products
Catalog Number Mfr. No. Quantity Price Quantity    

PR-N2511

 
promega™
N2511
2500U Each for $142.58

PR-N2515

 
promega™
N2515
10000U Each for $347.92
Description & Specifications

Specifications

For Use With (Application) RT-PCR, protection of mRNA in cDNA synthesis reactions, in-vitro transcription/translation, Increase yield and activity of polysomes, improvement of in-vitro virus replication, improvement of RNA translation in homologous systems
Storage Requirements Store at -20°C.

  • Inhibits a broad spectrum of RNases, including RNase A, RNase B, RNase C and human placental RNase
  • Does not inhibit RNase T1, S1 nuclease, RNase from Aspergillus, RNase H, or RNase ONE™ Ribonuclease
  • Compatible with the use of other enzymes, including SP6, T7 or T3 RNA Polymerase, ImProm-II™, AMV or M-MLV Reverse Transcriptase and Taq DNA Polymerase
  • Made in bacteria, minimizing the chances of human nucleic acid contamination
  • Unit Definition: Amount of RNasin RNase inhibitor required to inhibit the activity of 5ng of RNase A by 50%, activity is measured by the inhibition of hydrolysis of Cytidine 2,3'-cyclic Monophosphate by RNase A